{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:59:02Z","timestamp":1790852342189,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Both obesity and type 2 diabetes are among the risk factors for breast cancer development. Combined effect of these metabolic abnormalities on breast cancer risk however, has not been examined in premenopausal women. We tested this association in type 2 diabetic women, categorized as obese, overweight and normal body weight groups based on BMI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and methods<\/jats:title><jats:p>A total of 101 subjects were included in this study. Serum levels of IL-6, TNF-\u03b1, C reactive protein, leptin, TGF-\u03b1, adiponectin and insulin were measured by ELISA. Data were logarithmically transformed for variables not normally distributed. Analysis of variance with post-hoc Bonferroni was applied to compare the data between the groups. Simple and partial correlation coefficients between the variables were determined and a stepwise multiple linear regression analysis was performed to determine the relationships between the variables of interest.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Significantly increased levels of IL-6, C reactive protein, leptin and significantly decreased levels of adiponectin were found in obese group, while the levels of TNF-\u03b1 and TGF-\u03b1 were unaltered. A positive correlation between waist circumference and IL-6 was found in obese group. Similarly, C reactive protein, waist and hip circumferences were linearly correlated with BMI in obese group. Stepwise multiple linear regression analysis revealed several significant predictors for breast cancer risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Obesity and type 2 diabetes, owing to their effects on adipocytokines and inflammatory mediators, contribute to increased breast cancer risk in premenopausal women. This study emphasizes healthy life style and better management of these metabolic disorders to avoid the pathogenesis of breast cancer and of other chronic diseases.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1475-2840-8-33","type":"journal-article","created":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T06:16:31Z","timestamp":1245737791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women"],"prefix":"10.1186","volume":"8","author":[{"given":"Majed S","family":"Alokail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser M","family":"Al-Daghri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar S","family":"Al-Attas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajamul","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,23]]},"reference":[{"issue":"Suppl 1","key":"187_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000088231","volume":"20","author":"M Procopiou","year":"2005","unstructured":"Procopiou M, Philippe J: The metabolic syndrome and type 2 diabetes: epidemiological figures and country specificities. Cerebrovasc Dis. 2005, 20 (Suppl 1): 2-8. 10.1159\/000088231.","journal-title":"Cerebrovasc Dis"},{"issue":"Suppl 3","key":"187_CR2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/sj.ijo.0802804","volume":"28","author":"BM Popkin","year":"2004","unstructured":"Popkin BM, Gordon-Larsen P: The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes Relat Metab Disord. 2004, 28 (Suppl 3): S2-9. 10.1038\/sj.ijo.0802804.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"187_CR3","volume-title":"Breast cancer facts and figures 2005\u20132006","author":"American Cancer Society","year":"2006","unstructured":"American Cancer Society: Breast cancer facts and figures 2005\u20132006. 2006, Atlanta, GS: American Cancer Society Inc"},{"key":"187_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1532-5415.2005.00541.x","volume":"54","author":"EE Krebs","year":"2006","unstructured":"Krebs EE, Taylor BC, Cauley JA, Stone KL, Bowman PJ, Ensrud KE: Measures of adiposity and risk of breast cancer in older postmenopausal women. J Am Geriatr Soc. 2006, 54: 63-69. 10.1111\/j.1532-5415.2005.00541.x.","journal-title":"J Am Geriatr Soc"},{"key":"187_CR5","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ijc.22717","volume":"121","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Mantzoros CS, Wolk A: Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007, 121: 856-862. 10.1002\/ijc.22717.","journal-title":"Int J Cancer"},{"key":"187_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1023\/B:CACO.0000024225.14618.a8","volume":"15","author":"DA Lawlor","year":"2004","unstructured":"Lawlor DA, Smith GD, Ebrahim S: Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control. 2004, 15: 267-275. 10.1023\/B:CACO.0000024225.14618.a8.","journal-title":"Cancer Causes Control"},{"key":"187_CR7","first-page":"1361","volume":"11","author":"P Muti","year":"2002","unstructured":"Muti P, Quattrin T, Grant BJ: Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev. 2002, 11: 1361-1368.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"187_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","volume":"94","author":"T Key","year":"2002","unstructured":"Key T, Appleby P, Barnes I, Reeves G: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. Endogenous Hormones and Breast Cancer Collaborative Group. J Natl Cancer Inst. 2002, 94: 606-616.","journal-title":"J Natl Cancer Inst"},{"key":"187_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s005920200027","volume":"39","author":"S Fischer","year":"2002","unstructured":"Fischer S, Hanefeld M, Haffner SM: Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetol. 2002, 39: 105-110. 10.1007\/s005920200027.","journal-title":"Acta Diabetol"},{"key":"187_CR10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.33549\/physiolres.930479","volume":"53","author":"M Haluz\u00edk","year":"2004","unstructured":"Haluz\u00edk M, Par\u00edzkov\u00e1 J, Haluz\u00edk MM: Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res. 2004, 53: 123-29.","journal-title":"Physiol Res"},{"key":"187_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1385\/ENDO:26:1:019","volume":"26","author":"C Han","year":"2005","unstructured":"Han C, Zhang HT, Du L: Serum levels of leptin, insulin, and lipids in relation to breast cancer in china. Endocrine. 2005, 26: 19-24. 10.1385\/ENDO:26:1:019.","journal-title":"Endocrine"},{"key":"187_CR12","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1210\/jc.2006-1975","volume":"92","author":"SS Tworoger","year":"2007","unstructured":"Tworoger SS, Eliassen AH, Kelesidis T: Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab. 2007, 92: 1510-1516. 10.1210\/jc.2006-1975.","journal-title":"J Clin Endocrinol Metab"},{"key":"187_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0748-7983(95)96935-7","volume":"21","author":"KV Albuquerque","year":"1995","unstructured":"Albuquerque KV, Price MR, Badley RA: Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survival. Eur J Surg Oncol. 1995, 21: 504-509. 10.1016\/S0748-7983(95)96935-7.","journal-title":"Eur J Surg Oncol"},{"key":"187_CR14","first-page":"1427","volume":"19","author":"GJ Zhang","year":"1999","unstructured":"Zhang GJ, Adachi I: Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res. 1999, 19: 1427-1432.","journal-title":"Anticancer Res"},{"key":"187_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cyto.2004.04.002","volume":"27","author":"H Bozcuk","year":"2004","unstructured":"Bozcuk H, Uslu G, Samur M: Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine. 2004, 27: 58-65. 10.1016\/j.cyto.2004.04.002.","journal-title":"Cytokine"},{"key":"187_CR16","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1210\/jcem.87.5.8450","volume":"87","author":"JP Bastard","year":"2002","unstructured":"Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B: Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab. 2002, 87: 2084-2089. 10.1210\/jc.87.5.2084.","journal-title":"J Clin Endocrinol Metab"},{"key":"187_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/sj.ijo.0802718","volume":"28","author":"M Maachi","year":"2004","unstructured":"Maachi M, Pi\u00e9roni L, Bruckert E, Jardel C, Fellahi S, Hainque B, Capeau J, Bastard JP: Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord. 2004, 28: 993-997. 10.1038\/sj.ijo.0802718.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"187_CR18","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.metabol.2006.07.026","volume":"55","author":"YM Rolland","year":"2006","unstructured":"Rolland YM, Perry HM, Patrick P, Banks WA, Morley JE: Leptin and adiponectin levels in middle-aged postmenopausal women: associations with lifestyle habits, hormones, and inflammatory markers\u2013a cross-sectional study. Metabolism. 2006, 55: 1630-1636. 10.1016\/j.metabol.2006.07.026.","journal-title":"Metabolism"},{"key":"187_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.diabres.2005.10.025","volume":"72","author":"G Yuan","year":"2006","unstructured":"Yuan G, Zhou L, Tang J: Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Diabetes Res Clin Pract. 2006, 72: 244-250. 10.1016\/j.diabres.2005.10.025.","journal-title":"Diabetes Res Clin Pract"},{"key":"187_CR20","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1158\/1055-9965.EPI-05-0316","volume":"14","author":"D Il'yasova","year":"2005","unstructured":"Il'yasova D, Colbert LH, Harris TB: Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2413-2418. 10.1158\/1055-9965.EPI-05-0316.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"187_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/39335","volume":"389","author":"KT Uysal","year":"1997","unstructured":"Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 1997, 389: 610-614. 10.1038\/39335.","journal-title":"Nature"},{"key":"187_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/j.1365-2362.2004.01414.x","volume":"34","author":"A Jellema","year":"2004","unstructured":"Jellema A, Plat J, Mensink RP: Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest. 2004, 34: 766-773. 10.1111\/j.1365-2362.2004.01414.x.","journal-title":"Eur J Clin Invest"},{"key":"187_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/bcr425","volume":"4","author":"A Purohit","year":"2002","unstructured":"Purohit A, Newman SP, Reed MJ: The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res. 2002, 4: 65-69. 10.1186\/bcr425.","journal-title":"Breast Cancer Res"},{"key":"187_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/ijc.11624","volume":"108","author":"C Schairer","year":"2004","unstructured":"Schairer C, Hill D, Sturgeon SR, Fears T, Pollak M, Mies C, Ziegler RG, Hoover RN, Sherman ME: Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int J Cancer. 2004, 108: 773-779. 10.1002\/ijc.11624.","journal-title":"Int J Cancer"},{"key":"187_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/00004872-200018030-00002","volume":"18","author":"PH Peeters","year":"2000","unstructured":"Peeters PH, van Noord PA, Hoes AW, Fracheboud J, Gimbr\u00e8re CH, Grobbee DE: Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypertens. 2000, 18: 249-254. 10.1097\/00004872-200018030-00002.","journal-title":"J Hypertens"},{"key":"187_CR26","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/jnci\/djh216","volume":"96","author":"AS Furberg","year":"2004","unstructured":"Furberg AS, Veier\u00f8d MB, Wilsgaard T, Bernstein L, Thune I: Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst. 2004, 96: 1152-1160.","journal-title":"J Natl Cancer Inst"},{"key":"187_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.maturitas.2008.03.002","volume":"60","author":"C Pichard","year":"2008","unstructured":"Pichard C, Plu- Bureau, Neves-eCastro M, Gompel A: Insulin resistance, obesity and breast cancer risk. Maturitas. 2008, 60: 19-30. 10.1016\/j.maturitas.2008.03.002.","journal-title":"Maturitas"},{"issue":"1A","key":"187_CR28","first-page":"167","volume":"26","author":"YM Chong","year":"2006","unstructured":"Chong YM, Williams SL, Elkak A, Sharma AK, Mokbel K: Insulin-like growth factor 1 (IGF-1) and its receptor mRNA levels in breast cancer and adjacent non-neoplastic tissue. Anticancer Res. 2006, 26 (1A): 167-173.","journal-title":"Anticancer Res"},{"key":"187_CR29","doi-asserted-by":"crossref","first-page":"13606","DOI":"10.1016\/S0021-9258(17)43958-5","volume":"258","author":"J Massagu\u00e9","year":"1983","unstructured":"Massagu\u00e9 J: Epidermal growth factor-like transforming growth factor. I. Isolation, chemical characterization, and potentiation by other transforming factors from feline sarcoma virus-transformed rat cells. J Biol Chem. 1983, 258: 13606-13613.","journal-title":"J Biol Chem"},{"key":"187_CR30","first-page":"1527","volume":"138","author":"J Lundy","year":"1991","unstructured":"Lundy J, Schuss A, Stanick D, McCormack ES, Kramer S, Sorvillo JM: Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters. Am J Pathol. 1991, 138: 1527-1534.","journal-title":"Am J Pathol"},{"key":"187_CR31","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T","volume":"92","author":"JR Daling","year":"2001","unstructured":"Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL: Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer. 2001, 92: 720-729. 10.1002\/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T.","journal-title":"Cancer"},{"key":"187_CR32","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1001\/archinte.166.21.2395","volume":"166","author":"KB Michels","year":"2006","unstructured":"Michels KB, Terry KL, Willett WC: Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med. 2006, 166: 2395-2402. 10.1001\/archinte.166.21.2395.","journal-title":"Arch Intern Med"},{"key":"187_CR33","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/oxfordjournals.aje.a009963","volume":"150","author":"Z Huang","year":"1999","unstructured":"Huang Z, Willett WC, Colditz GA: Waist circumference, waist: hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol. 1999, 150: 1316-1324.","journal-title":"Am J Epidemiol"},{"key":"187_CR34","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00125-006-0207-6","volume":"49","author":"K Rapp","year":"2006","unstructured":"Rapp K, Schroeder J, Klenk J: Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia. 2006, 49: 945-952. 10.1007\/s00125-006-0207-6.","journal-title":"Diabetologia"},{"key":"187_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/aje\/kwf050","volume":"156","author":"PJ Mink","year":"2002","unstructured":"Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR: Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol. 2002, 156: 349-352. 10.1093\/aje\/kwf050.","journal-title":"Am J Epidemiol"},{"key":"187_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/01.HYP.34.2.320","volume":"34","author":"M Soler","year":"1999","unstructured":"Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C: Hypertension and hormone-related neoplasms in women. Hypertension. 1999, 34: 320-325.","journal-title":"Hypertension"},{"key":"187_CR37","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1161\/hc5001.101061","volume":"104","author":"AM Wallace","year":"2001","unstructured":"Wallace AM, McMahon AD, Packard CJ: Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation. 2001, 104: 3052-3056. 10.1161\/hc5001.101061.","journal-title":"Circulation"},{"key":"187_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1055\/s-2003-39054","volume":"35","author":"M Wauters","year":"2003","unstructured":"Wauters M, Considine RV, Yudkin JS, Peiffer F, De Leeuw I, Van Gaal LF: Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion. Horm Metab Res. 2003, 35: 92-96. 10.1055\/s-2003-39054.","journal-title":"Horm Metab Res"},{"key":"187_CR39","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995, 95: 2409-2415. 10.1172\/JCI117936.","journal-title":"J Clin Invest"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-8-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T19:29:30Z","timestamp":1685042970000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-8-33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,23]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["187"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-8-33","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,23]]},"assertion":[{"value":"28 March 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"33"}}